ublituximab

Italy

Drugs containing this active substance

  • BRIUMVI

    Briumvi is used for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), characterized by attacks of symptoms followed by periods of improvement or absence of symptoms.

    Form: solution for infusion, concentrate

    Active substance Dosage
    ublituximab -

    ATC: L04AG14

    Manufacturer: NEURAXPHARM PHARMACEUTICALS, S.L